April 8, 2015Open Access
No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov NCT00122811 (July 2005).